How does excess adiposity impact your patients?
Learn more about how managing excess weight can impact both obesity and type 2 diabetes (T2D)
Obesity is a chronic, relapsing disease driven by multiple factors often beyond an individual’s control1,2
Obesity is a chronic disease, characterized by excess adiposity (excess body fat), which drives many life-limiting complications3
For most people with obesity, weight reduction is associated with prevention or improvement of a wide range of complications2
Weight reduction is often difficult to maintain due to the body’s biological adaptations1,2
Successfully treating obesity requires a comprehensive plan that accounts for patients’ individual goals3
Excess weight is one of several components of T2D pathophysiology and is associated with uncontrolled HbA1c.4
Among patients with T2D, a treatment approach that addresses excess weight as early as possible could provide more clinical benefit than focusing on glycemic control alone.4
Guidelines now recommend individualized treatment, including options that address several mechanisms driving the progression of T2D.4
Get started by exploring the underlying issues of obesity, why treatment is so important, and how to best support your patients who have overweight or obesity.
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
Cefalu W, Bray G, Home P, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2015;38(8):1567-1582. doi:10.2337/dc15-1081
Wharton S, Lau DCW, Vallis M, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020;192(31):E875-e891. doi:10.1503/cmaj.191707
Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753-2786. doi:10.2337/dci22-0034